This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.
A new phase III clinical trial of early stage breast cancer patients has shown that a molecule designed to home in on nearby lymph nodes is just as accurate as current techniques, but faster, more specific and easier to use.
We care about your feedback. Let us know how we can improve your CancerCompass experience.